Intelligence Platform

Patents

Browse 311 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 9243051

Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T-cells

United States Government as represented by the Department of Veterans Affairs · Granted Tue Jan 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9238799

Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9228007

Recombinant human progenitor cells, engineered human thymocytes, and engineered human T ce

The Regents of the University of California · Granted Tue Jan 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9217024

ADDL receptor polypeptides, polynucleotides and host cells for recombinant production

Acumen Pharmaceuticals, Inc. · Granted Tue Dec 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9198950

Recombinant bacterium comprising a toxin/antitoxin system

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Dec 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9181530

Infectious hepatitis E virus genotype 3 recombinants

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9175049

Recombinant mycobacterium avium subsp. paratuberculosis proteins induce immunity and prote

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9169326

Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic canc

PRECISION BIOLOGICS, INC. · Granted Tue Oct 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9163068

Influenza virus recombinant proteins

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Tue Oct 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9144605

Recombinant rift valley fever virus encoding a dominant-negative inhibitor of DSRNA-depend

The Board of Regents of the University of Texas System · Granted Tue Sep 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9133478

Modified vaccinia Ankara (MVA) virus recombinants comprising heterologous coding sequences

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9133480

Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructured insertio

granted patent

US 9120868

Recombinantly expressed Plasmodium CelTOS antigen and methods of use thereof

The United States of America as represented by the Secretary of the Army · Granted Tue Sep 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9050285

Recombinant bacterium capable of eliciting an immune response against Streptococcus pneum

The United States of America National Institutes of Health (NH), U.S. Dept. of Health and Human Services (DHHS) · Granted Tue Jun 09 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9045742

Recombinant Edwardsiella bacterium

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9040059

Recombinant bacterium capable of eliciting a protective immune response against C. perfrin

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue May 26 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8993519

Method of treatment for neutropenia using stable formulations of recombinant human albumin

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8932846

Unmarked recombinant intracellular pathogen immunogenic compositions expressing high level

The Regents of the University of California · Granted Tue Jan 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8900818

Recombinant antigen for diagnosis and prevention of murine typhus

United States of America as represented by the Secretary of the Air Force · Granted Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8895018

Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric imp

The United States of America as represented by the Department of Veteran Affairs · Granted Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8846057

Recombinant live attenuated foot-and-mouth disease (FMD) vaccine containing mutations in t

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8835386

Activity of recombinant equine follicle stimulating hormone

The Regents of the University of California · Granted Tue Sep 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8802090

Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic canc

PRECISION BIOLOGICS, INC. · Granted Tue Aug 12 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8802836

Cloning and recombinant productions of Vespula venom protease and methods of use thereof

PLS-Design GmbH · Granted Tue Aug 12 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 07 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted